Sr. No. |
Lesion |
No. of Cases |
% |
Total (%) |
1. |
Benign
|
72
(81.82%) |
||
Pleomorphic Adenoma |
70 |
97.25% |
||
Monomorphic Adenoma |
02 |
2.75% |
||
2 |
Malignant |
16
(18.18%) |
||
Mucoepidermoid Carcinoma |
04 |
25.0% |
||
Pleomorphic Adenoma Undergoing Malignant Change |
04 |
25.0% |
||
Squamous
Cell Carcinoma |
02 |
12.5% |
||
Undifferentiated
Carcinoma |
06 |
37.5% |
||
Total |
88 |
Sr. No. |
Lesions |
00-10 |
11-20 |
21-30 |
31-40 |
41-50 |
51-60 |
>60 |
1. |
Pleomorphic
Adenoma |
00 |
02 |
20 |
10 |
10 |
26 |
02 |
% |
-- |
2.85 |
28.56 |
14.29 |
14.29 |
37.14 |
2.87 |
|
2. |
Monomorphic
Adenoma |
00 |
00 |
02 |
00 |
00 |
00 |
00 |
% |
-- |
-- |
100.0 |
-- |
-- |
-- |
-- |
|
3. |
Mucoepidermoid
Carcinoma |
00 |
00 |
00 |
00 |
00 |
04 |
00 |
% |
-- |
-- |
-- |
-- |
-- |
100.0 |
-- |
|
4. |
Pleomorphic Adenoma Undergoing Malignant Change |
00 |
00 |
00 |
00 |
00 |
02 |
02 |
% |
-- |
-- |
-- |
-- |
-- |
50.0 |
50.0 |
|
5. |
Squamous
Cell Carcinoma |
00 |
00 |
00 |
00 |
00 |
02 |
00 |
% |
-- |
-- |
-- |
-- |
-- |
100.0 |
-- |
|
6. |
Undifferentiated
Carcinoma |
00 |
00 |
00 |
02 |
02 |
02 |
00 |
% |
-- |
-- |
-- |
33.33 |
33.33 |
33.33 |
-- |
|
|
Total |
00 |
02 |
22 |
12 |
12 |
36 |
04 |
% |
-- |
2.27 |
25.0 |
13.64 |
13.64 |
40.9 |
4.55 |
Sr. No. |
Lesion |
Male |
% |
Female |
% |
1. |
Pleomorphic
Adenoma |
36 |
48.49 |
34 |
51.51 |
2. |
Monomorphic
Adenoma |
00 |
--- |
02 |
100.0 |
3. |
Mucoepidermoid
Carcinoma |
02 |
50.0 |
02 |
50.0 |
4. |
Pleomorphic Adenoma Undergoing Malignant Change |
04 |
100.0 |
00 |
--- |
5. |
Suamous
Cell Carcinoma |
04 |
66.67 |
02 |
33.33 |
6. |
Undifferentiated
Carcinoma |
02 |
100.0 |
00 |
|
|
Total |
48 |
54.55 |
40 |
45.45 |
Sr.
No. |
Author |
Year |
Benign
(%) |
Malignant
(%) |
1. |
Cajulis et al[15] |
1997 |
67.21 |
32.79 |
2. |
Cristallini et al[16] |
1997 |
90.90 |
09.10 |
3. |
Yang et al[19] |
1997 |
69.10 |
30.90 |
4. |
Shafkat et al[17] |
2002 |
84.09 |
15.91 |
5. |
Khandekar et al[18] |
2006 |
80.55 |
19.45 |
6. |
Present Study |
2009 |
81.82 |
18.18 |